Page 3 of 5
Results 61 - 90 of 127
9078_DMD-icon9
DMD and Gene Therapy: What's on the Horizon?
No image set
Updates in Duchenne Muscular Dystrophy: A Focus on Emerging Gene Therapy
No image set
LGMD: Mutation-specific Nomenclature
No image set
LGMD Symptomatology
No image set
LGMD Mutations and Disease Types
No image set
Tests and Outcomes - DMD
No image set
Genes, Exons, and the Pathophysiology of DMD
No image set
The Natural History of DMD
No image set
Updates in SMA: Cure SMA Conference Coverage (CME/CE)
No image set
New and Emerging Options for the Management of MS
No image set
Comorbidities and Selection of DMTs
No image set
Conference Coverage on DMD and LGMD: Latest Developments
No image set
Management of Breakthrough Disease Activity in MS
No image set
Minimizing Neurodegenerative Damage in Patients with MS
No image set
Recognizing Progressive Disease: A Challenge in the MS Clinic
No image set
MDA Conference Coverage
No image set
Engaging Patients with MS and the Care Team in Shared Decision-Making
No image set
Advances in MS Assessment: Biomarkers and Imaging
No image set
Defining the Clinical Course of Multiple Sclerosis
No image set
Engaging the Patient in Treatment Choices
No image set
DMT Treatment Review
No image set
WMS Conference Coverage on DMD and LGMD: Experts Reporting From the Field
No image set
Updates in SMA: WMS Conference Coverage (CME/CE)
No image set
Updates in SMA: WMS Conference Coverage
No image set
SMA: Introduction and Key Concepts
No image set
Conference Coverage on DMD & LGMD
No image set
Controversies in Progressive MS: Managing Progressive Disease
No image set
Controversies in Progressive MS: Transition to Progressive Disease
No image set
Controversies in Progressive MS: Focus on Diagnosis
No image set
Hereditary Transthyretin Amyloidosis: Case Studies
Page 3 of 5

Search